Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential surrogate biomarker in patients with isocitrate dehydrogenase mutant (IDHm) intrahepatic cholangiocarcinoma (ICC) Proceeding/Conference:Journal of Clinical Oncology | 2013 | ||
2014 | |||
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma Journal:Journal for ImmunoTherapy of Cancer | 2021 |